US Maltodextrin Market

ID: MRFR/FnB/19735-HCR
200 Pages
Snehal Singh
Last Updated: April 06, 2026
US Maltodextrin Market Size, Share, Industry Trend & Analysis Research Report: By Source (Corn, Wheat, Potato, Others), By Form (Spray Dried Powder, Agglomerated) andBy Application (Food and Beverage, Pharmaceuticals, Cosmetics & Personal Care Products, Agriculture)- Forecast to 2035
US Maltodextrin Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.62%
2024 Market Size$ 722.82 Million
2025 Market Size$ 756.21 Million
2035 Market Size$ 1,187.93 Million
Key Players
Cargill
Tate & Lyle
Roquette Freres
ADM
Ingredion
MGP Ingredients
Opportunities
  • Growth in Convenience Foods
  • Expansion of Sports Nutrition Products
  • Increased Focus on Dietary Supplements
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Source (USD Million)
      1. 4.1.1 Corn
      2. 4.1.2 Wheat
      3. 4.1.3 Potato
      4. 4.1.4 Others
    2. 4.2 Pharmaceutical, BY Form (USD Million)
      1. 4.2.1 Spray Dried Powder
      2. 4.2.2 Agglomerated
    3. 4.3 Pharmaceutical, BY Application (USD Million)
      1. 4.3.1 Food & Beverage
      2. 4.3.2 Pharmaceuticals
      3. 4.3.3 Cosmetics & Personal Care Products
      4. 4.3.4 Agriculture
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Cargill (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Tate & Lyle (GB)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Roquette Freres (FR)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 ADM (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Ingredion (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 MGP Ingredients (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Grain Processing Corporation (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Emsland Group (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY SOURCE
    3. 6.3 US MARKET ANALYSIS BY FORM
    4. 6.4 US MARKET ANALYSIS BY APPLICATION
    5. 6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
    6. 6.6 RESEARCH PROCESS OF MRFR
    7. 6.7 DRO ANALYSIS OF PHARMACEUTICAL
    8. 6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    9. 6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    11. 6.11 PHARMACEUTICAL, BY SOURCE, 2024 (% SHARE)
    12. 6.12 PHARMACEUTICAL, BY SOURCE, 2024 TO 2035 (USD Million)
    13. 6.13 PHARMACEUTICAL, BY FORM, 2024 (% SHARE)
    14. 6.14 PHARMACEUTICAL, BY FORM, 2024 TO 2035 (USD Million)
    15. 6.15 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    16. 6.16 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SOURCE, 2025-2035 (USD Million)
      2. 7.2.2 BY FORM, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Maltodextrin Market Segmentation

US Maltodextrin Market By Source (USD Million, 2025-2035)

  • Corn
  • Wheat
  • Potato
  • Others

US Maltodextrin Market By Form (USD Million, 2025-2035)

  • Spray Dried Powder
  • Agglomerated

US Maltodextrin Market By Application (USD Million, 2025-2035)

  • Food & Beverage
  • US Maltodextrin Markets
  • Cosmetics & Personal Care Products
  • Agriculture
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.